PBT outcomes for localized unresectable hepatocellular carcinoma.
03/01/2019
/
Publications
/
Survival
Toxicity
A MD Anderson study published in the Green Journal reported outcomes of forty-six patients with HCC, Child-Pugh class of A or B, no prior radiotherapy treated...
Consensus Report From the Miami Liver PT Conference.
03/05/2019
/
Publications
This paper is based on the Liver Focus Group supported by IBA. An International group of 22 liver cancer experts from 18 institutions were brought together in...
What Conditions Make PBT Financially Viable in Western Canada?
11/11/2018
/
Publications
This is a business case and concluded the potential for a financially viable PBT facility in Western Canada. A single-vault, compact PBT unit operating 10 hours...
Toxicity and Survival After IMPT Versus Passive Scattering PT for NSCLC.
10/10/2020
/
Publications
/
Toxicity
IMPT
This MD Anderson study compared toxicity profiles and clinical outcomes after IMPT versus PSPT for 139 patients with locally advanced NSCLC. Compared to the...
Literature Review of PBT for Prostate Cancer in Japan.
01/01/2019
/
Publications
A literature review on published works related to proton beam therapy for prostate cancer in Japan. 23 articles were analyzed including fourteen observational...
LT results of a phase II study of hypofractionated PT for prostate cancer
01/01/2019
/
Publications
A study by the Korean group of National Cancer Center. Eighty-two patients with T1-3bN0M0 prostate cancer were randomized to one of five arms: Arm 1, 60 cobalt...
Analysis of Gastrointestinal Toxicity in Patients Receiving PBT for Prostate Cancer
08/08/2018
/
Publications
/
Toxicity
A study by the Seattle group. 192 prostate cancer patients were treated with PBT. With the median follow-up of 1.7 years, most of the observed GI toxicity (>90%...
Comparison of Grade 4 Lymphopenia With PT Vs Photon Therapy for Esophageal Cancer.
01/01/2019
/
Publications
/
Survival
Grade 4 lymphopenia (G4L) during radiation therapy (RT) is associated with higher rates of distant metastasis and decreased overall survival. 79 patients...
Campus launch
26/10/2021
/
Webinar
IBA CAMPUS is the largest community sharing knowledge and experience in proton therapy.
This community is made up of technical, medical and business profiles.
...
PBT is a safe and feasible treatment for patients with second primary lung cancer after lung resection.
10/12/2018
/
Publications
A study from Japan reported 19 patients who were diagnosed with second primary lung cancer after lung resection, underwent PBT. This study reported the three...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.